Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...

On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of atopic dermatitis: nonstop itching. The campaign’s ad spot features atopic ...

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics ( KYMR -0.86%) notched an almost 23% share price gain across this week. That made it a standout in the ever-volatile ...

Atopic dermatitis (AD) is a widespread ... However, recent developments have reignited interest in AD treatments, especially ...

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

Against the backdrop of Music City’s biggest weekend, leading experts and frontline clinicians will gather in downtown Nashville, Tennessee, for one of dermatology’s most impactful educational events ...

Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

KT-621 targets STAT6, aiming to provide a biologics-like effect through a convenient oral medication. When will the Phase 2b trials for KT-621 start? Phase 2b trials in atopic dermatitis and ...